The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Sunday Q & A (2017 Conference) (LDN, low dose naltrexone)
Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)
Pharmacist-Prescriber Michael McCaughley - LDN Specialist (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
The LDN Research Trust's 8th LDN Specialist
The LDN Side Effect Survey Results from 2020 - Jill Brook, MA (2021 Conference) (LDN, low dose naltrexone)
Jill Brook, MA is a Research Advisor to the LDN Research Trust. In this presentation she shares the results of the 2020 LDN Side Effect Survey.
The EMF Toxicity Epidemic - Protection and Treatment - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)
Longevity - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)
Developing outcome centric, territory-specific access protocols for the provision of niche product - John Bardsley (2021 Conference) (LDN, low dose naltrexone)
John Bardsley is managing director of Thistle Pharma Ltd. LDN is an unlicensed medicine. Much of what he is talking about pertains specifically to the UK sector, and may apply to your own territories as well.